BPA Call HT001415A0010-0006

Award Date 9/29/15
Potential Completion Date 9/30/16
Potential Value $331K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Health Agency (DHA), a defense agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and laboratory equipment. The $2,800,000.00 Blanket Purchase Agreement (BPA) Call contract is for the provision of reagents and peripheral consumables. The contract is not designated as a set-aside. Roche Diagnostics holds multiple Indefinite Delivery Vehicles (IDVs) and BPAs with federal agencies such as...
This is a $8,352.94 firm fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in-vitro diagnostics, reagents, and laboratory instruments. The award is for the delivery of laboratory reagents for the Defense Health Agency's (DHA) clinical diagnostics testing program. This BPA call order does not have a set-aside designation, indicating Roche Diagnostics competed...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical laboratory equipment. The $5,979,596 contract is for chemistry and immunoassay testing services to be performed at Fort Belvoir, Virginia, with a performance period ending on December 31, 2024. This contract is not designated as a set-aside. Roche Diagnostics holds several...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Defense's Bureau of Medicine and Surgery to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $500,000.00 contract is for the provision of reagents and consumables, with a period of performance ending on September 30, 2015. Roche Diagnostics has also been awarded other Indefinite Delivery Vehicles (IDVs) by the Department of...
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for in vitro diagnostic testing services. The contract, which is a Blanket Purchase Agreement (BPA) call valued at $741,441.86, was awarded by the Defense Health Agency (DHA) with a completion date of September 5, 2020. The contract has a firm fixed price pricing type and does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro...
This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $712,750.00, was awarded by the Defense Health Agency (DHA) for "IHC COST PER TEST" services. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract vehicle, likely a Blanket Purchase Agreement (BPA) or Indefinite...
This is a federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of reagents and peripheral supplies. The contract was awarded by the Defense Health Agency, is a Blanket Purchase Agreement (BPA) Call with a firm fixed price, and has a potential value of $2,238,187.65. The contract has no set-aside designation. Roche Diagnostics is a foreign-owned, for-profit organization that manufactures in vitro diagnostics, reagents, laboratory...
This is a Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $3,330,384.44, is for the provision of reagents and peripherals with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating Roche Diagnostics competed openly in the...
This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, with a ceiling value of $302,000.00, is a Blanket Purchase Agreement (BPA) Call placed by the Defense Health Agency (DHA) for the procurement of REAGENTS AND CONSUMABLES. This BPA is part of a larger Indefinite Delivery Contract vehicle held by Roche Diagnostics to provide chemistry reagents...
This is a Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract is for REAGENTS AND SUPPLIES with a ceiling value of $59,787.69 and an ultimate completion date of September 30, 2019. This BPA call is part of a larger $37 million BPA with DHA for immunochemistry and clinical...

This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract, valued at $330,646.79, is for the delivery of controls, reagents, and consumables. This award is a call order under a Blanket Purchase Agreement (BPA) established by DHA, which has a $37 million ceiling and provides immunochemistry and clinical chemistry testing capabilities to the agency. Roche Diagnostics holds several other significant Indefinite Delivery Vehicle (IDV) contracts with the Department of Veterans Affairs and Department of Defense for a range of medical diagnostic technologies. This contract does not have a set-aside designation, indicating Roche Diagnostics competed openly for the award.

Generated 4/26/25, 10:10 AM